A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis

Not Applicable

Completed

• Conditions: Meningitis, Cryptococcal; HIV Infections

• Registration Number: NCT00002305
• Lead Sponsor: Pfizer

Brief Summary

To compare the safety and effectiveness of fluconazole and amphotericin B, alone or in combination with flucytosine, as treatment for acute cryptococcal meningitis.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 1999-11-02
• Study First Submitted QC: 2001-08-30
• Study First Posted: 2001-08-31
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (45)

Univ of Alabama at Birmingham; 🇺🇸 Birmingham, Alabama, United States

Tucson Veterans Administration Med Ctr; 🇺🇸 Tucson, Arizona, United States

UCLA CARE Ctr; 🇺🇸 Los Angeles, California, United States

Dr Shelly Gordon; 🇺🇸 San Francisco, California, United States

Dr Martin Mass; 🇺🇸 San Francisco, California, United States

Dr Paul Rothman; 🇺🇸 Sherman Oaks, California, United States

Christiana Hosp / Med Ctr of Delaware; 🇺🇸 Wilmington, Delaware, United States

George Washington Univ Med Ctr; 🇺🇸 Washington, District of Columbia, United States

Univ of Miami School of Medicine; 🇺🇸 Miami, Florida, United States

Univ of South Florida; 🇺🇸 Tampa, Florida, United States

Scroll for more (35 remaining)